- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01839422
Imaging of New Learning in Severe Alzheimer's Disease Patients (INCAS)
Functionnal Magnetic Resonnance Imaging (fMRI)Study of Cerebral Substrates of New Musical and Pictorial Learning in Alzheimer Patients
This research attempts to better understand the altered and preserved memory mechanisms in Alzheimer disease, particularly to better apprehend learning implicit memory processes, and give a scientific support to non-pharmalogical interventions. At the present time, it is possible to delay the emergence of the symptoms related to this disease, eventually to decrease it, but not to cure it. Yet, care these patients became a crucial question and the solutions proposed to healthy aging people are not appropriate for Alzheimer patients who present specific disorders. The improvement of the quality of life of the institutionalized patients lies on a better comprehension of their disorders but also of their preserved abilities. The literature testifies of a great heterogeneity in the clinical expression of this disease, however we noticed two constants with regard to the capabilities generally announced as being preserved, on one hand, the implicit memory, and on the other hand the artistic aptitudes, and more particularly musical capabilities.
Patients with Alzheimer disease present a particularly severe and early deterioration of episodic memory. Thus, at the beginning of the disease the explicit acquisition of new knowledge becomes increasingly difficult. However, some clinical observations, such as new learning of unknown songs, even with patients at a severe stage of the illness, seem to support the assumption of a preservation of some implicit learning abilities. Indeed, several studies already showed preserved implicit memory capabilities among patients with Alzheimer disease, mostly at the beginning stage of the illness: preserved effects of perceptual priming, procedural learning. Thus, we are mainly interested by the effects of exposure and the rising of a feeling of familiarity, both showing preserved implicit learning abilities, for moderate to severe Alzheimer patients. However, no study was carried out to date using the neuroimaging techniques, among Alzheimer patients at a moderated to severe stage of illness, with the main objective to identify the cerebral substrates implied in the learning of new knowledge.
Indeed, several studies already showed preserved implicit memory capabilities among patients with Alzheimer disease, mostly were performed at the beginning stage of the illness and none of them have studied theses learning abilities for moderate to severe Alzheimer patients.
The objective of this work is to specify, in severe form of Alzheimer disease, the cognitive mechanisms allowing the memorizing (feeling of familiarity) of new information and thus to highlight neural networks underlying this learning process (recently learned stimuli vs old stimuli). The goal is to propose a positive image of the Alzheimer patients, in understanding which cognitive mechanisms and cerebral areas allow these learning capabilities.
20 patients Alzheimer at a moderate to severe stage, 20 patients at a mild to moderate stage of the illness, and 20 healthy aging participants, are selected after a neurological interview and a neuropsychological evaluation. The whole of the included participants take part of the experimental protocol organized in two phases: - the phase of familiarization and the phase of test. The phase of familiarization consists of the repeated exposure (daily session before the MRI acquisition) of new songs and new painting until obtaining a high feeling of familiarity for each item. The phase of test is carried out in the 3T MRI camera, it comprises an anatomical (T1, T2 MRI) and a functional acquisitions. The functional acquisition corresponds to a passive listening and seeing tasks of musical and pictorial stimuli. Finally, all participants realize a debriefing phase that allows obtaining a feedback on the familiarity of stimuli presented during the functional acquisition.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Anticipato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Caen, Francia, 14000
- Reclutamento
- GIP Cyceron
-
Investigatore principale:
- Vincent de La Sayette, MD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Native language: French
Medical, neurological, neuropsychological and neuroradiological depth in accordance with the criteria for inclusion and exclusion-specific population, that is to say:
- Healthy Elderly volunteers: over 60 years old, living at home, without memory complaints, normal performances compared to the age and the educational level for all tests of the diagnostic battery.
- Alzheimer's patients: presenting the standard criteria of NINCDS-ADRDA probable Alzheimer's disease, including abnormal global cognitive function and deficits in at least two cognitive domains identified by the diagnostic battery.
Exclusion Criteria:
- The sudden onset of cognitive impairments (as opposed to their slow and gradual installation in Alzheimer's disease)
- A chronic neurological, psychiatric, endocrine, hepatic or infectious complaint
- A history of major disease (an uncontrolled diabetes, a lung, heart, metabolic, hematologic, endocrine disease or a severe cancer);
- A medication that may interfere with memory or metabolic measures
- A alcohol or drugs abuse
- The cons-indications to MRI (claustrophobia, metallic object in the body).
- A predominantly left-hand (score below 50% in Edinburgh Inventory)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Controls
Memory assessment.
Brain imaging examination MRI.
|
Cognitive assessment : Neuropsycological tests, learning sessions of new stimuli.
Brain imaging examination : Structural and functional MRI to compare differences between each sample.
|
Sperimentale: Beginner Alzheimer's Disease patients
Memory assessment.
Brain imaging examination MRI.
|
Cognitive assessment : Neuropsycological tests, learning sessions of new stimuli.
Brain imaging examination : Structural and functional MRI to compare differences between each sample.
|
Sperimentale: Severe Alzheimer's Disease patients
Memory assessment.
Brain imaging examination MRI.
|
Cognitive assessment : Neuropsycological tests, learning sessions of new stimuli.
Brain imaging examination : Structural and functional MRI to compare differences between each sample.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
---|---|
Succesful learning of new songs and paintings, succesful MRI acquisitions.
Lasso di tempo: 10 days max. One week for the learning sessions, before MRI scans done one or two days after.
|
10 days max. One week for the learning sessions, before MRI scans done one or two days after.
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 2011-A00351-40
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Malattia di Alzheimer
-
ProgenaBiomeReclutamentoMalattia di Alzheimer | Malattia di Alzheimer, esordio precoce | Malattia di Alzheimer, esordio tardivo | Malattia di Alzheimer 1 | Malattia di Alzheimer 2 | Malattia di Alzheimer 3 | Malattia di Alzheimer 4 | Malattia di Alzheimer 7 | Malattia di Alzheimer 17 | Malattia di Alzheimer 5 | Malattia di Alzheimer... e altre condizioniStati Uniti
-
Cognito Therapeutics, Inc.ReclutamentoDeterioramento cognitivo | Demenza | Malattia di Alzheimer | Compromissione cognitiva lieve | Declino cognitivo | Malattia di Alzheimer, esordio precoce | Malattia di Alzheimer, esordio tardivo | MCI | Demenza Alzheimer | Demenza lieve | Demenza di tipo Alzheimer | Compromissione cognitiva, lieve | Malattia di Alzheimer... e altre condizioniStati Uniti
-
Centre Hospitalier Universitaire de NiceCompletatoPaziente Predemenziale di Alzheimer | Paziente demenziale di Alzheimer | TestimoneFrancia
-
AphiosNon ancora reclutamentoDemenza | Malattia di Alzheimer 1 | Malattia di Alzheimer 2 | Malattia di Alzheimer 3
-
Massachusetts Institute of TechnologyReclutamentoMalattia di Alzheimer | Malattia di Alzheimer, esordio precoce | Malattia di Alzheimer, esordio tardivo | Il morbo di Alzheimer | Morbo di Alzheimer (sottotipi inclusi) | AlzheimerStati Uniti
-
Istanbul University - Cerrahpasa (IUC)Non ancora reclutamentoDemenza, tipo Alzheimer | Il morbo di Alzheimer | Demenza di AlzheimerTacchino
-
University of RostockDZNE, German Center for Neurodegenerative Disorders, GermanySconosciutoDemenza di tipo AlzheimerGermania
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...ReclutamentoDemenza | Malattia di Alzheimer | Malattia prodromica di Alzheimer | Malattia di Alzheimer preclinicaStati Uniti
-
University of ArizonaNational Institute on Aging (NIA); University of Southern California; Syneos Health e altri collaboratoriReclutamentoMalattie Neurodegenerative | Demenza di Alzheimer | Malattia di Alzheimer ad esordio tardivoStati Uniti
-
Capital Medical UniversityPeking University First Hospital; The First Affiliated Hospital of Anhui Medical... e altri collaboratoriReclutamentoMalattia di Alzheimer | Malattia di Alzheimer familiare (FAD)Cina
Prove cliniche su Memory assessment
-
Talita Cumi Ltd.Aetrex Worldwide IncCompletatoPaura di cadere | Male al piede | Funzionalità del piedeRegno Unito
-
London Health Sciences CentreCompletato
-
University of California, DavisIscrizione su invitoCompromissione cognitiva lieve | Malattia prodromica di Alzheimer | Disturbi cognitivi soggettiviStati Uniti
-
University of California, BerkeleyCompletatoDisordine del sonno | Disregolazione circadianaStati Uniti
-
New York State Psychiatric InstituteUniversity of Miami; Columbia University; University of Southern California; Feinstein...Attivo, non reclutantePartecipanti saniStati Uniti
-
Firat UniversitySconosciutoAttività fisica
-
Guy's and St Thomas' NHS Foundation TrustPhilips HealthcareCompletato
-
Metropolitan University CollegeCompletatoDisturbi della deglutizioneDanimarca
-
Sun Yat-sen UniversityCompletato
-
Memorial Sloan Kettering Cancer CenterAttivo, non reclutanteCancro gastrointestinale | Ruolo dell'infermiera | Malattia gastrointestinaleStati Uniti